Author:
Kivistö Kari T.,Niemi Mikko
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference87 articles.
1. S. M. Singhvi, H. Y. Pan, R. A. Morrison, and D. A. Willard. Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. Br. J. Clin. Pharmacol. 29:239–243 (1990).
2. T. Hatanaka. Clinical pharmacokinetics of pravastatin. Mechanisms of pharmacokinetic events. Clin. Pharmacokinet. 39:397–412 (2000).
3. B. A. Hamelin and J. Turgeon. Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol. Sci. 19:26–37 (1998).
4. D. W. Everett, T. J. Chando, G. C. Didonato, S. M. Singhvi, H. Y. Pan, and S. H. Weinstein. Biotransformation of pravastatin sodium in humans. Drug Metab. Dispos. 19:740–748 (1991).
5. J. Triscari, D. O’Donnell, M. Zinny, and H. Y. Pan. Gastrointestinal absorption of pravastatin in healthy subjects. J. Clin. Pharmacol. 35:142–144 (1995).
Cited by
118 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献